| Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients D Weintraub, J Koester, MN Potenza, AD Siderowf, M Stacy, V Voon, ... Archives of neurology 67 (5), 589-595, 2010 | 1694 | 2010 |
| Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease AE Lang, S Gill, NK Patel, A Lozano, JG Nutt, R Penn, DJ Brooks, ... Annals of neurology 59 (3), 459-466, 2006 | 1104 | 2006 |
| Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD JG Nutt, KJ Burchiel, CL Comella, J Jankovic, AE Lang, ER Laws Jr, ... Neurology 60 (1), 69-73, 2003 | 903 | 2003 |
| Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial WJ Marks, RT Bartus, J Siffert, CS Davis, A Lozano, N Boulis, J Vitek, ... The Lancet Neurology 9 (12), 1164-1172, 2010 | 720 | 2010 |
| A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of neurology 59 (12), 1937-1943, 2002 | 714 | 2002 |
| Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ... Archives of neurology 61 (7), 1044-1053, 2004 | 685 | 2004 |
| Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group B Ravina, K Marder, HH Fernandez, JH Friedman, W McDonald, ... Movement Disorders 22 (8), 1061-1068, 2007 | 587 | 2007 |
| Impulse control disorders in Parkinson disease: a multicenter case–control study V Voon, M Sohr, AE Lang, MN Potenza, AD Siderowf, J Whetteckey, ... Annals of neurology 69 (6), 986-996, 2011 | 461 | 2011 |
| Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease E Driver-Dunckley, J Samanta, M Stacy Neurology 61 (3), 422-423, 2003 | 393 | 2003 |
| Non-motor symptoms in Parkinson’s disease A Park, M Stacy Journal of neurology 256, 293-298, 2009 | 381 | 2009 |
| Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease R Pahwa, MA Stacy, SA Factor, KE Lyons, F Stocchi, BP Hersh, LW Elmer, ... Neurology 68 (14), 1108-1115, 2007 | 367 | 2007 |
| Pesticide exposure and risk of Parkinson's disease: a family-based case-control study DB Hancock, ER Martin, GM Mayhew, JM Stajich, R Jewett, MA Stacy, ... BMC neurology 8, 1-12, 2008 | 366 | 2008 |
| Clinical spectrum of impulse control disorders in Parkinson's disease D Weintraub, AS David, AH Evans, JE Grant, M Stacy Movement Disorders 30 (2), 121-127, 2015 | 351 | 2015 |
| Assessment of interrater and intrarater reliability of the Fahn–Tolosa–Marin Tremor Rating Scale in essential tremor MA Stacy, RJ Elble, WG Ondo, SC Wu, J Hulihan, TRS Study Group Movement disorders 22 (6), 833-838, 2007 | 321 | 2007 |
| Impulsive and compulsive behaviors in Parkinson's disease AH Evans, AP Strafella, D Weintraub, M Stacy Movement disorders: official journal of the Movement Disorder Society 24 (11 …, 2009 | 299 | 2009 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 298 | 2014 |
| Identification of motor and nonmotor wearing‐off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment M Stacy, A Bowron, M Guttman, R Hauser, K Hughes, JP Larsen, P LeWitt, ... Movement disorders: official journal of the Movement Disorder Society 20 (6 …, 2005 | 297 | 2005 |
| Medical management of levodopa-associated motor complications in patients with Parkinson’s disease J Jankovic, M Stacy CNS drugs 21, 677-692, 2007 | 276 | 2007 |
| Gene delivery of neurturin to putamen and substantia nigra in P arkinson disease: a double‐blind, randomized, controlled trial C Warren Olanow, RT Bartus, TL Baumann, S Factor, N Boulis, M Stacy, ... Annals of neurology 78 (2), 248-257, 2015 | 265 | 2015 |
| Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients RT Bartus, TL Baumann, J Siffert, CD Herzog, R Alterman, N Boulis, ... Neurology 80 (18), 1698-1701, 2013 | 225 | 2013 |
